Shares of Novavax Inc. NVAX, -3.55% slid 3.55% to $248.16 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA, +0.10% rising 0.10% to 34,798.00 and the NASDAQ Composite Index COMP, -0.03% falling 0.03% to 15,047.70. The stock’s fall snapped a three-day winning streak. Novavax Inc. closed $83.52 short of its 52-week high ($331.68), which the company achieved on February 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Replimune Group Inc. REPL, -4.19% fell 4.19% to $32.26, VBI Vaccines Inc. VBIV, -4.62% fell 4.62% to $3.30, and AnaptysBio Inc. ANAB, -2.67% fell 2.67% to $27.34. Trading volume (3.0 M) remained 2.1 million below its 50-day average volume of 5.1 M.